Epigenetic dysregulation in neurodegenerative diseases and potential treatment

Epigenetic dysregulation in neurodegenerative diseases and potential treatment

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Bibliografiset tiedot
Päätekijä:	Mostofa, Golam
Muut tekijät:	Khan, Tanisha Tabassum Sayka
Aineistotyyppi:	Opinnäyte
Kieli:	English
Julkaistu:	Brac University 2022
Aiheet:	Epigenetics Dysregulation Methylation Acetylation Alzheimer’s disease Parkinson’s disease Huntington’s disease Epidrugs
Linkit:	http://hdl.handle.net/10361/17309

Samankaltaisia teoksia

Potential treatments for epigenetic dysregulation in neurological diseases
Tekijä: Zaman, Rubaiyat
Julkaistu: (2024)

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
Tekijä: Dey, Manashi
Julkaistu: (2024)

Gene editing for neurodegenerative diseases-A review
Tekijä: Sharna, Anika Islam
Julkaistu: (2023)

Role of epigenetics in the development of metabolic disorders: a review
Tekijä: Mita, Tanzia Mohsin
Julkaistu: (2024)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
Tekijä: Alim, Abdul
Julkaistu: (2023)

Impact of Lifestyle on the Disease Progression of Parkinson’s
Tekijä: Annee, Israt Jahan
Julkaistu: (2023)

Role of circular RNA in neurological disease
Tekijä: Salsabil, Labiba
Julkaistu: (2024)

Parkinson’s disease and COVID-19: treatment and patient management during a pandemic
Tekijä: Afsana, Nourin
Julkaistu: (2022)

Diagnostic biomarkers of Parkinson’s disease: The present and the future
Tekijä: Ferdous, Labiba
Julkaistu: (2023)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
Tekijä: Chowdhury, Sariya Uzrat
Julkaistu: (2022)

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
Tekijä: Tabassum, Nadira
Julkaistu: (2024)

Role of protein’s and future treatment options for Alzheimer’s Disease
Tekijä: Islam, Md. Irfath
Julkaistu: (2023)

A review on cardiovascular development and epigenetics
Tekijä: Srity, Nafisa Alam
Julkaistu: (2024)

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
Tekijä: Shehab, Habibul Mohsin
Julkaistu: (2024)

Treatment options of Parkinson’s disease: How far we are from the cure?
Tekijä: Afreen, Nuraia
Julkaistu: (2021)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
Tekijä: Tamanna, Mst. Taskia
Julkaistu: (2023)

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
Tekijä: Karmaker, Swastika
Julkaistu: (2024)

Glymphatic system: a pathway for managing endogenous metabolites in CNS
Tekijä: Tasneem, Sadia
Julkaistu: (2021)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
Tekijä: Ishrat, Nowshin
Julkaistu: (2024)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
Tekijä: Saha, Bithi Rani
Julkaistu: (2023)

Parkinson's disease in Bangladesh: An evaluation of the public knowledge and awareness
Tekijä: Chowdhury, Amal
Julkaistu: (2024)

Marine compounds in the treatment of Alzheimer’s disease
Tekijä: Parveen, Sanjana
Julkaistu: (2022)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
Tekijä: Hassan, Md. Muhtaz
Julkaistu: (2020)

Review on: the mechanism and function of Glia in parkinson's disease
Tekijä: Abedin, Khondokar Mezbahul
Julkaistu: (2023)

Alzheimer's disease and marriage : an intimate account /
Tekijä: Wright, Lore K.
Julkaistu: (1993)

Therapeutic implication of senescent cell elimination in neurodegenerative diseases
Tekijä: Key, Nasrin Sultana
Julkaistu: (2023)

Emerging therapies of Alzheimer’s disease: a comprehensive review
Tekijä: Tasin, Md Abtahi
Julkaistu: (2023)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
Tekijä: Aziz, Farhin
Julkaistu: (2019)

Early detection of parkinson’s disease using image processing and artificial neural network
Tekijä: Rumman, Mosarrat, et al.
Julkaistu: (2018)

Prospective detection methods for Tau protein: an important biomarker for Alzheimer’s disease
Tekijä: Afra, Sumaiya
Julkaistu: (2022)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
Tekijä: Bakar, Osama Bin Abu
Julkaistu: (2024)

Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
Tekijä: Mahee, Sadique Abdal
Julkaistu: (2024)

A look into parkinson’s disease and the implications of gene therapy as a novel clinical approach
Tekijä: Islam, Md. Rakibul
Julkaistu: (2023)

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
Tekijä: Halim, Rabea
Julkaistu: (2022)

Exploring the role of programmed cell death protein 1 in alzheimer’s disease associated autoimmunity
Tekijä: Aana, Afsara Sumon
Julkaistu: (2021)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
Tekijä: Haque, Mushfiqul
Julkaistu: (2019)

A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
Tekijä: Jahan, Nusrat
Julkaistu: (2023)

Infection and communicable diseases /
Tekijä: Brettle, Raymond Patrick
Julkaistu: (1984)

Exploring Alzheimer's disease prediction with XAI in various neural network models
Tekijä: Rahman, Quazi Ashikur, et al.
Julkaistu: (2022)

Exploring the potential of organic molecules in the treatment of covid-19
Tekijä: Mondol, Winifred Claire
Julkaistu: (2024)